8-K: HeartCore Enterprises Secures 15th 'Go IPO' Consulting Contract with tmsuk Co.Ltd., Adding $500,000 and 3% Equity Warrant

HeartCore Enterprises, a Tokyo-based enterprise software and data consulting firm, announced a new consulting agreement with tmsuk Co.Ltd. to assist its NASDAQ listing efforts, securing $500,000 in fees and a warrant for 3% of tmsuk's fully diluted capital.

Summary

• HeartCore Enterprises, Inc. entered into a Consulting and Services Agreement with tmsuk Co.Ltd. on May 30, 2025, to assist tmsuk in its efforts to go public and list on the Nasdaq Stock Market.
• Under the nine-month agreement, HeartCore will provide services including assistance with selecting legal, underwriting, and auditing firms, preparing internal controls documentation for IPO/de-SPAC, converting accounting data to U.S. GAAP, creating an English webpage, and preparing investor presentations.
• HeartCore will receive $500,000 in cash compensation, paid in installments: $200,000 on May 30, 2025, $150,000 on August 30, 2025, and $150,000 on November 30, 2025.
• Additionally, HeartCore will receive a warrant to acquire 3% of tmsuk's fully diluted share capital, which is fully earned and vested as of the effective date.
• The issuance of the warrant is subject to tmsuk's stockholder approval; if not obtained within 90 days, the parties will seek an alternative arrangement of equivalent value.
• This marks HeartCore's 15th "Go IPO" consulting service contract win.

Sentiment

Score: 8

Explanation: The announcement is highly positive for HeartCore, securing a significant new contract with substantial cash and equity compensation, demonstrating continued demand for its specialized services, and outlining clear growth strategies despite broader market uncertainties. The only minor contingency is the warrant approval, which has an alternative plan.

Positives

• Secured a new "Go IPO" consulting contract, marking the 15th such win, demonstrating continued demand for HeartCore's specialized services.
• The agreement provides a guaranteed cash compensation of $500,000 over nine months, contributing to HeartCore's revenue stream.
• HeartCore will receive a warrant for 3% of tmsuk's fully diluted share capital, offering potential upside if tmsuk successfully lists and its valuation increases.
• The warrant is deemed fully earned and vested from the effective date, providing immediate value recognition.
• The company is actively expanding its "Go IPO" services beyond Japan, with a seminar planned for South Korea in September 2025, indicating growth initiatives.
• HeartCore has a pipeline of other companies exploring U.S. exchange listings and expects to guide "a few clients" through the final stages of their IPO process this year.

Negatives

• The warrant issuance is subject to tmsuk's stockholder approval, introducing a contingency that could alter the form of compensation if not approved within 90 days.
• HeartCore's services are non-exclusive, meaning tmsuk can engage other consultants.
• HeartCore is explicitly prohibited from providing certain services like legal advice, accounting services, investment advisory, or broker/dealer activities, which limits the scope of their engagement.
• The "Go IPO" services are dependent on the uncertain IPO market conditions.

Risks

• IPO Market Uncertainty: The CEO acknowledged "ongoing uncertainty of the IPO market," which could impact the success and timeline of tmsuk's listing and, by extension, HeartCore's future "Go IPO" service pipeline.
• Warrant Issuance Contingency: The 3% equity warrant is subject to tmsuk's stockholder approval; failure to obtain this approval within 90 days would require the parties to agree on an alternative compensation method of equivalent value, potentially introducing delays or changes to the expected equity upside.
• Competition: HeartCore's engagement is on a non-exclusive basis, meaning tmsuk could engage other consultants, potentially diluting HeartCore's influence or future opportunities.
• Regulatory Compliance: HeartCore explicitly states it does not provide legal or accounting advice, nor acts as an investment advisor or broker/dealer, which means tmsuk will need to secure these services independently, potentially impacting the overall efficiency or cost of the IPO process.

Future Outlook

HeartCore Enterprises remains cautiously optimistic about its "Go IPO" pipeline, with several early-stage discussions ongoing with other companies exploring U.S. exchange listings. The company plans to expand its "Go IPO" presence beyond Japan by hosting its first South Korea "Go IPO" seminar in September 2025. HeartCore anticipates guiding a few existing clients nearing the final stages of their IPO process to completion this year.

Management Comments

• "Even with the ongoing uncertainty of the IPO market, we continue to see steady interest in our Go IPO services from Japanese growth companies." Sumitaka Kanno, HeartCore CEO.
• "With our first Go IPO contract secured for the year, we remain cautiously optimistic about our pipeline and are actively engaged in several early-stage discussions with other companies exploring a U.S. exchange listing." Sumitaka Kanno, HeartCore CEO.
• "In September 2025, we will host our first South Korea Go IPO seminar, aimed at expanding Go IPOs presence beyond Japan and adding to our growing pipeline." Sumitaka Kanno, HeartCore CEO.
• "With a few clients nearing the final stages of their IPO process, we look forward to guiding them through to completion this year." Sumitaka Kanno, HeartCore CEO.

Industry Context

This announcement highlights HeartCore's continued focus and success in its "Go IPO" consulting services, specifically targeting Japanese growth companies seeking U.S. exchange listings. Despite general IPO market uncertainty, HeartCore is demonstrating consistent demand for its specialized expertise in navigating the complexities of U.S. public offerings for foreign entities, including U.S. GAAP conversion and SEC filing preparation. The planned expansion into South Korea indicates a strategic move to broaden its geographic market for these services, leveraging its established model.

Comparison to Industry Standards

• The document does not provide specific comparable companies or projects for this type of "Go IPO" consulting service agreement to assess against global benchmarks.
• The compensation structure, combining a fixed fee ($500,000) with an equity warrant (3% of fully diluted capital), is a common model in advisory services for early-stage or growth companies seeking public listings, aligning the consultant's incentives with the client's success.
• The explicit exclusion of legal, accounting, and broker-dealer services is standard for non-licensed consulting firms, ensuring compliance with regulatory frameworks.

Stakeholder Impact

• Shareholders: Positive impact due to new revenue stream, potential equity upside from the tmsuk warrant, and validation of HeartCore's "Go IPO" business model. The expansion into South Korea also signals future growth.
• Employees: Continued work and potential for growth in the "Go IPO" division.
• Customers (tmsuk): Will receive comprehensive support for its U.S. public listing efforts, leveraging HeartCore's expertise.
• Future Clients: The successful securing of the 15th contract and expansion plans may attract more Japanese and South Korean companies seeking U.S. listings.

Next Steps

• HeartCore to provide consulting services to tmsuk for nine months, assisting with its NASDAQ listing efforts.
• tmsuk to make two further cash payments of $150,000 each to HeartCore on the three-month and six-month anniversaries of the effective date.
• tmsuk to seek stockholder approval for the issuance of the 3% equity warrant to HeartCore within 90 days of the effective date, or agree on an alternative compensation method.
• HeartCore to host its first South Korea "Go IPO" seminar in September 2025 to expand its market presence.
• HeartCore expects to guide "a few clients" nearing the final stages of their IPO process to completion this year.

Key Dates

Recommendation

Keywords

HeartCore Enterprises, HTCR, tmsuk, Go IPO, Consulting Agreement, NASDAQ Listing, Initial Public Offering, De-SPAC, Financial Consulting, SEC Filing, 8-K, Japan, U.S. GAAP, Equity Warrant, Corporate Advisory